[Anakinra treatment in refractory systemic onset juvenile arthritis].
Garrido Colino
C
C
Saavedra Lozano
J
J
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D010148:Intractable Pain
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein